Lv5
1169 积分 2024-01-08 加入
Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval Summary
11天前
已完结
Osimertinib: First Global Approval
11天前
已完结
Development of EGFR Family Small Molecule Inhibitors for Anticancer Intervention: An Overview of Approved Drugs and Clinical Candidates
12天前
已完结
Deciphering the Intrinsic Chemistry of Protein‐Enhanced Type I Photodynamic Processes
29天前
已完结
Glutathione/Cysteine Dual‐Consuming Prodrug Nanoassemblies for Potentiated Gas‐Photodynamic Therapy
29天前
已完结
Effective Degradation of Wild‐Type and Mutant EGFR Using Self‐Assembling Peptide‐Derived PROTAC Nanoparticles (NanoTACs) for Cancer Therapy
1个月前
已完结
Polyethylene glycol phospholipids encapsulated silicon 2,3-naphthalocyanine dihydroxide nanoparticles (SiNcOH-DSPE-PEG(NH 2 ) NPs) for single NIR laser induced cancer combination therapy
1个月前
已完结
Tailored-Designed Ligands for Enantioselective Gold(I)-Catalyzed Activation of Alkynes
1个月前
已关闭
A Bioactive Photosensitizer for Hypoxia‐Tolerant Molecular Targeting‐Photo‐Immunotherapy of Malignant Tumor
2个月前
已完结
Effect of nintedanib, a triple angiokinase inhibitor, on EGFR and HER2 in colorectal cancer (CRC) models, and rational for its combinations with the ErbB family blocker afatinib
2个月前
已关闭
皖公网安备34019202002308
